You are here: Industry Insights > Johnson & Johnson

News List

Johnson & Johnson announces a lead vaccine candidate for COVID-19 worldpharmanews
April 08, 2020
Johnson & Johnson announced the selection of a lead COVID-19 vaccine candidate from constructs it has been working on since January 2020.
Johnson & Johnson Announces Lead Vaccine Candidate for COVID-19, Partners with HHS americanpharmaceuticalreview
April 03, 2020
Johnson & Johnson announced the selection of a lead COVID-19 vaccine candidate from constructs it has been working on since January 2020.
Johnson & Johnson Announces a Lead Vaccine Candidate for COVID-19 expresspharma
April 01, 2020
The company will also establish a new US Vaccine manufacturing capabilities and additional production capacity outside the US to begin production at risk to help ensure global vaccine supply.
J&J partners with BARDA to commit $1bn to Covid-19 vaccine development pharmaceutical-technology
March 31, 2020
Johnson & Johnson (J&J) has expanded its partnership with the US Department for Health and Human Service (HSS)’s Biomedical Advanced Research and Development Authority (BARDA).
J&J says no evidence darunavir works against coronavirus pharmaceutical-technology
March 18, 2020
Johnson and Johnson (J&J) have noted the lack of evidence that its HIV drug darunavir has antiviral activity against SARS-CoV-2, the novel coronavirus that causes Covid-19.
J&J NSCLC Drug Gets Breakthrough Designation contractpharma
March 12, 2020
Bispecific antibody targets activating and resistant EGFR and MET mutations and amplifications in non-small cell lung cancer.
Pulmatrix Announces Agreement with Lung Cancer Initiative americanpharmaceuticalreview
January 06, 2020
Pulmatrix has entered into a licensing and development agreement with the Lung Cancer Initiative at Johnson & Johnson. Through the agreement, the Lung Cancer Initiative gains an option to access a portfolio of narrow spectrum kinase inhibitors intended fo
Johnson & Johnson Acquires TARIS Biomedical americanpharmaceuticalreview
January 02, 2020
Johnson & Johnson announced the acquisition of TARIS Biomedical, a privately-owned biotechnology company specializing in the development of a novel drug delivery technology ...
DARZALEX (Daratumumab) Shows Overall Survival Benefit and Continued Improvement in Progression-Free Survival in Patients with Newly Diagnosed Multiple Myeloma Who Are Ineligible for Transplant firstwordpharma
December 10, 2019
The Janssen Pharmaceutical Companies of Johnson & Johnson announcedoverall survival (OS) results from the Phase 3 ALCYONE study (Abstract #859) ...
Oklahoma Judge Fines Johnson & Johnson $572 Billion Over Opioid Drug Crisis drugs
August 27, 2019
An Oklahoma judge on Monday ruled against one of America's biggest companies, Johnson & Johnson -- fining it $572 million as part of the first trial of an opioid maker sued by...

Previous page 1 2 3 4 5 6 7 8 9 10 ... 15 16 Next page